Marcus Vass > Osborne Clarke LLP > London, England > Lawyer Profile
Osborne Clarke LLP Offices

ONE LONDON WALL
EC2Y 5EB
LONDON
EC2Y 5EB
England
- Firm Profile
- Go to...
Marcus Vass

Position
Please see full biography at osborneclarke.com/lawyers/marcus-vass/
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
A range of multinational biopharmaceutical and medical device companies turn to Osborne Clarke LLP for assistance with work such as multi-jurisdictional patent litigation, life sciences M&A and financing transactions. A foursome of partners oversee the team: Will James‘ contentious IP expertise has seen him litigate before the UK courts and the UPC. Matthew Edwards is praised for his ‘smooth and successful’ handling of transactions. His corporate expertise is relied upon by the likes of BioNtech. Marcus Vass is well-versed in the digital health sector, and Richard Wilkinson heads up the firm’s healthcare subsector. Tim Harris is a further key contact and extends the unit’s international IP litigation strength.
Lawyer Rankings
Top Tier Firm Rankings
- TMT (technology, media and telecoms) > Artificial intelligence
- Dispute resolution > Commercial litigation: mid-market
- Employment > Health and safety
- Real estate > Property litigation
- Public sector > Healthcare
- TMT (technology, media and telecoms) > Media: Advertising & marketing
- TMT (technology, media and telecoms) > Media: Digital content & social
- Real estate > Property litigation
- Projects, energy and natural resources > Oil and gas
- Industry focus > Retail and consumer
- Corporate and commercial > Venture capital
Firm Rankings
- Corporate and commercial > Equity capital markets – small-mid cap
- TMT (technology, media and telecoms) > Fintech: regulatory
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Corporate and commercial > International business reorganisations
- TMT (technology, media and telecoms) > IT and telecoms
- Industry focus > Life sciences and healthcare
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- TMT (technology, media and telecoms) > Media: Film & TV
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Projects, energy and natural resources > Power (including electricity and nuclear)
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Real estate > Property litigation
- Transport > Rail
- Corporate and commercial > Commercial contracts
- Real estate > Construction: non-contentious
- Risk advisory > Data protection, privacy and cybersecurity
- Employment > Employee share schemes
- Corporate and commercial > Financial services: contentious
- TMT (technology, media and telecoms) > Fintech: corporate and commercial
- Crime, fraud and licensing > Fraud: civil
- Investment fund formation and management > Hedge funds
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Investment fund formation and management > Real estate funds
- Projects, energy and natural resources > Renewables
- TMT (technology, media and telecoms) > Reputation management
- Industry focus > TMT
- Real estate > Commercial property: development
- Real estate > Commercial property: investment
- Real estate > Construction: contentious
- Public sector > Education: institutions
- Employment > Employers
- Real estate > Environment
- Risk advisory > ESG
- Projects, energy and natural resources > Infrastructure: Project finance and development
- Insurance > Insurance litigation: for policyholders
- Dispute resolution > International arbitration
- TMT (technology, media and telecoms) > PATMA: Trade mark attorneys
- Private client > Personal tax, trusts and probate
- Real estate > Planning
- Insurance > Product liability: defendant
- Real estate > Property finance
- Dispute resolution > Tax litigation and investigations
- Corporate and commercial > Corporate tax
- Employment > Immigration
- Investment fund formation and management > Private funds
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > EU and competition